MDxHealth SA (MDXH):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:MDxHealth SA (MDXH) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7497
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:76
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. The company’s products portfolio includes ConfirmMDx, which detects absence or presence of prostate cancer; SelectMDx for prostate cancer; and AssureMDx for bladder cancer. Its pipeline products include InformMDx, SelectMDx (Point of Care) and MonitorMDx which is being developed for Prostate Cancer Test. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform. It also offers biomarker development services to many pharmaceutical companies. MDxHealth markets its products through sales forces, partnerships and distributors. The company has operations in, the Netherlands, Belgium and the US. MDxHealth is headquartered in Herstal, Liege, Belgium.

MDxHealth SA (MDXH) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MDxHealth SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
MDxHealth SA, Medical Equipment Deals By Type, 2012 to YTD 2018 8
MDxHealth SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
MDxHealth SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 10
MDxHealth SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
MDxHealth SA, Medical Equipment, Deal Details 13
Venture Financing 13
NovioGendix Raises Funds Through Venture Financing 13
Partnerships 14
MDxHealth Enters into Licensing Agreement with Koninklijke Philips 14
MdxHealth Enters into Licensing Agreement with Ghent University 15
Qiagen Enters into Licensing Agreement with MDxHealth 16
MdxHealth Enters into Licensing Agreement with Erasmus MC 17
MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 18
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 19
Ugentec Enters into Agreement with MDxHealth 20
MDxHealth Enters into Partnership Agreement with IPS Genomix 21
MDxHealth Enters into Agreement with QUT bluebox 22
MDxHealth Enters into Agreement with Maastricht University 23
MDxHealth Enters into Agreement with Exact Sciences 24
MdxHealth Enters into Distribution Agreement with Istituto Diagnostico Varelli 25
MdxHealth Enters into Distribution Agreement with AceCGT Life Science 26
MdxHealth Enters into Distributon Agreement with HIFU CLINIC Prostate Cancer Center 27
MDxHealth Enters into Distribution Agreement with European Health Centre Innovation 28
MDxHealth Enters into Distribution Agreement with Teva Pharmaceutical 29
Cerba HealthCare Enters into Agreement with MDxHealth 30
Andros Men’s Health Clinic Partners with MdxHealth 31
MdxHealth Enters into Agreement with Radboud University Nijmegen Medical Centre 32
MDxHealth Enters into Co-Promotion Agreement with Miraca Life Sciences for ConfirmMDx 33
MDxHealth Enters Co-Marketing Agreement With American Pathology Partners For ConfirmMDx 34
MDxHealth And Long Island Pathology Enter Into Marketing Agreement For Prostate Cancer 35
MDxHealth Enters Into Agreement With Teva Pharma To Commercialize Two Cancer Tests In Israel 36
MDxHealth And Bostwick Labs Enter Into Co-Marketing Agreement For Prostate Cancer Test 37
MDxHealth Enters Into Agreement With HistoGeneX For Molecular Diagnostic Testing 38
MDxHealth Enters Into Co-Marketing Agreement With Summit Pharma 39
MDxHealth Enters Into Co-Promotion Agreement With Plus Diagnostics For ConfirmMDx 40
NovioGendix Enters Into Co-Development Agreement With DDL Diagnostic For New IVD Prostate Cancer Test 41
Equity Offering 42
MDxHealth Prices Private Placement of Shares for USD44 Million 42
MDxHealth Raises USD22.4 Million in Private Placement of Shares 43
MdxHealth Raises USD31.5 Million in Private Placement of Shares 44
MdxHealth Raises USD15.4 Million in Private Placement of Shares 45
MDxHealth Completes Private Placement Of Shares For US$23.6 Million 46
MdxHealth Completes Private Placement Of Shares For US$12.5 Million 47
Asset Transactions 48
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 48
Acquisition 49
MdxHealth Acquires NovioGendix 49
MDxHealth SA – Key Competitors 50
MDxHealth SA – Key Employees 51
MDxHealth SA – Locations And Subsidiaries 52
Head Office 52
Other Locations & Subsidiaries 52
Recent Developments 53
Financial Announcements 53
Aug 30, 2018: MDxHealth announces half year 2018 financial results 53
Apr 24, 2018: MDxHealth Reports First Quarter 2018 Financial Results 56
Feb 22, 2018: MDxHealth Reports Financial Year 2017 Results 58
Nov 02, 2017: MDxHealth Nine Month Trading Update 62
Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results 65
May 08, 2017: MDxHealth Trading Update: January to April 2017 67
Feb 23, 2017: MDxHealth Reports Financial Year 2016 Results 68
Jan 09, 2017: MDxHealth Announces Preliminary Update on 2016 Results and Appointment of CFO 71
Corporate Communications 72
Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion 72
Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion 73
Other Significant Developments 74
Apr 27, 2018: MDxHealth releases 2017 Annual Report 74
Mar 22, 2018: MDxHealth Successfully Completes a EUR 36 Million (USD 44 million)(1) Capital Increase 75
Appendix 76
Methodology 76
About GlobalData 76
Contact Us 76
Disclaimer 76

List of Tables
MDxHealth SA, Medical Equipment, Key Facts, 2017 2
MDxHealth SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
MDxHealth SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
MDxHealth SA, Medical Equipment Deals By Type, 2012 to YTD 2018 8
MDxHealth SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
MDxHealth SA, Deals By Market, 2012 to YTD 2018 10
MDxHealth SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 11
NovioGendix Raises Funds Through Venture Financing 13
MDxHealth Enters into Licensing Agreement with Koninklijke Philips 14
MdxHealth Enters into Licensing Agreement with Ghent University 15
Qiagen Enters into Licensing Agreement with MDxHealth 16
MdxHealth Enters into Licensing Agreement with Erasmus MC 17
MdxHealth Enters into Licensing Agreement with Oncgnostics for Epigenetic PCR Technology 18
MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 19
Ugentec Enters into Agreement with MDxHealth 20
MDxHealth Enters into Partnership Agreement with IPS Genomix 21
MDxHealth Enters into Agreement with QUT bluebox 22
MDxHealth Enters into Agreement with Maastricht University 23
MDxHealth Enters into Agreement with Exact Sciences 24
MdxHealth Enters into Distribution Agreement with Istituto Diagnostico Varelli 25
MdxHealth Enters into Distribution Agreement with AceCGT Life Science 26
MdxHealth Enters into Distributon Agreement with HIFU CLINIC Prostate Cancer Center 27
MDxHealth Enters into Distribution Agreement with European Health Centre Innovation 28
MDxHealth Enters into Distribution Agreement with Teva Pharmaceutical 29
Cerba HealthCare Enters into Agreement with MDxHealth 30
Andros Men's Health Clinic Partners with MdxHealth 31
MdxHealth Enters into Agreement with Radboud University Nijmegen Medical Centre 32
MDxHealth Enters into Co-Promotion Agreement with Miraca Life Sciences for ConfirmMDx 33
MDxHealth Enters Co-Marketing Agreement With American Pathology Partners For ConfirmMDx 34
MDxHealth And Long Island Pathology Enter Into Marketing Agreement For Prostate Cancer 35
MDxHealth Enters Into Agreement With Teva Pharma To Commercialize Two Cancer Tests In Israel 36
MDxHealth And Bostwick Labs Enter Into Co-Marketing Agreement For Prostate Cancer Test 37
MDxHealth Enters Into Agreement With HistoGeneX For Molecular Diagnostic Testing 38
MDxHealth Enters Into Co-Marketing Agreement With Summit Pharma 39
MDxHealth Enters Into Co-Promotion Agreement With Plus Diagnostics For ConfirmMDx 40
NovioGendix Enters Into Co-Development Agreement With DDL Diagnostic For New IVD Prostate Cancer Test 41
MDxHealth Prices Private Placement of Shares for USD44 Million 42
MDxHealth Raises USD22.4 Million in Private Placement of Shares 43
MdxHealth Raises USD31.5 Million in Private Placement of Shares 44
MdxHealth Raises USD15.4 Million in Private Placement of Shares 45
MDxHealth Completes Private Placement Of Shares For US$23.6 Million 46
MdxHealth Completes Private Placement Of Shares For US$12.5 Million 47
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 48
MdxHealth Acquires NovioGendix 49
MDxHealth SA, Key Competitors 50
MDxHealth SA, Key Employees 51
MDxHealth SA, Subsidiaries 52

List of Figures
MDxHealth SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
MDxHealth SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
MDxHealth SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
MDxHealth SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
MDxHealth SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 7
MDxHealth SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 8
MDxHealth SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 9
MDxHealth SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 10

★海外企業調査レポート[MDxHealth SA (MDXH):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Total Brain Ltd (TTB):企業の財務・戦略的SWOT分析
    Summary Total Brain Ltd (TBL) formerly, Brain Resource Ltd is a healthcare service provider that offers therapies. The company carries out research and development of brain products. TBL’s products comprise iSPOT, Total Brain and MyBrainSolutions. The company’s Total Brain is a brain health solution …
  • Future Plc (FUTR):企業の財務・戦略的SWOT分析
    Summary Future Plc (Future) is a media company that offers media and digital business solutions various customers. The company offers its services in various areas such as technology, photography, creative and design, games, advertising and film and music. It provides licensing and syndication, expo …
  • ProQR Therapeutics NV (PRQR):製薬・医療:M&Aディール及び事業提携情報
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Kerr Corp:企業の戦略的SWOT分析
    Kerr Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Power Corporation of Canada:企業の戦略・SWOT・財務情報
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Circassia Pharmaceuticals Plc (CIR):医療機器:M&Aディール及び事業提携情報
    Summary Circassia Pharmaceuticals plc (Circassia) develops and manufactures drugs for the treatment of allergy and respiratory diseases such as asthma. The company’s marketed products include Niox used to assist asthma management and Tudorza for the treatment of chronic obstructive pulmonary disease …
  • Metlifecare Ltd (MET):企業の財務・戦略的SWOT分析
    Metlifecare Ltd (MET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Robinson Helicopter Company, Inc.:企業の戦略・SWOT・財務分析
    Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Robinson Helicopter Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sarawak Energy Berhad:企業の戦略的SWOT分析
    Sarawak Energy Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PT Tigaraksa Satria Tbk (TGKA):企業の財務・戦略的SWOT分析
    PT Tigaraksa Satria Tbk (TGKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Lietuvos energijos gamyba, AB (LNR1L):電力:M&Aディール及び事業提携情報
    Summary Lietuvos energijos gamyba, AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company tra …
  • Immuron Ltd (IMC):企業の財務・戦略的SWOT分析
    Summary Immuron Ltd (Immuron), formerly Anadis Ltd is a biopharmaceutical company that develops oral immunotherapy therapeutics using polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. It pro …
  • Cyclacel Pharmaceuticals Inc (CYCC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cyclacel Pharmaceuticals Inc (Cyclacel) is a biopharmaceutical company that develops oral therapies. The company develops small molecule drugs that target various phases of cell cycle control for the treatment of cancer and other serious diseases. Its products include sapacitabine, selicicli …
  • DURECT Corp (DRRX)-医療機器分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Ameritas Mutual Holding Company:企業の戦略的SWOT分析
    Ameritas Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • CHDI Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CHDI Foundation Inc (CHDI) is a non-profit biomedical research organization that discovers and develops drugs for Huntington’s disease. The organization’s activities include identification and validation of therapeutic targets, drug discovery and development, and clinical studies and trials. …
  • Gunvor Group Limited:石油・ガス:M&Aディール及び事業提携情報
    Summary Gunvor Group Limited (Gunvor) is a vertically integrated energy trading company. It is one of the global traders of physical crude oil; refined products and energy; and metals and bulk materials. The company provides integrated trading products and logistics service to connect upstream suppl …
  • Garden Fresh Restaurants, LLC:企業の戦略・SWOT・財務分析
    Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report Summary Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Huishang Bank Corp Ltd:企業の戦略・SWOT・財務分析
    Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆